{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:30:08Z","timestamp":1786365008546,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd009782","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000}}],"reference-count":80,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009782.pub2","type":"journal-article","created":{"date-parts":[[2016,1,17]],"date-time":"2016-01-17T07:14:01Z","timestamp":1453014841000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery"],"prefix":"10.1002","volume":"2016","author":[{"given":"Jin-Wei","family":"Cheng","sequence":"first","affiliation":[{"name":"Shanghai Changzheng Hospital, Second Military Medical University; Department of Ophthalmology; 415 Fengyang Road Shanghai China 200003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wei","family":"Cheng","sequence":"additional","affiliation":[{"name":"Ludong University; School of Life Sciences; 186 Hongqi Road Yantai China 264025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Li","family":"Wei","sequence":"additional","affiliation":[{"name":"Shanghai Changzheng Hospital, Second Military Medical University; Department of Ophthalmology; 415 Fengyang Road Shanghai China 200003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Cai","family":"Lu","sequence":"additional","affiliation":[{"name":"Second Military Medical University; Center for New Drug Evaluation; 800 Xiangyin Road Shanghai China 200433"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IJG.0b013e318287abf3","article-title":"Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study","volume":"24","author":"Akkan","year":"2015","journal-title":"Journal of Glaucoma"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajo.2011.08.005","article-title":"Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy","volume":"153","author":"Nilforushan","year":"2012","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD009782.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3109\/02713683.2014.935441","article-title":"Ranibizumab versus mitomycin C in primary trabeculectomy - a pilot study","volume":"40","author":"Pro","year":"2015","journal-title":"Current Eye Research"},{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0004|cit4","first-page":"797","article-title":"Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma","volume":"5","author":"Sedghipour","year":"2011","journal-title":"Clinical Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD009782.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/IJG.0b013e31821826b2","article-title":"Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial","volume":"21","author":"Sengupta","year":"2012","journal-title":"Journal of Glaucoma"},{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/IJG.0b013e3182883c0c","article-title":"Deep sclerectomy with bevacizumab and mitomycin C: a comparative study","volume":"24","author":"Anand","year":"2015","journal-title":"Journal of Glaucoma"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2415-11-1","article-title":"ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma \u00a0- Study Protocol","volume":"11","author":"Bochmann","year":"2011","journal-title":"BMC Ophthalmology"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0008|cit8","first-page":"ARVO E-Abstract","article-title":"Subconjunctival bevacizumab as an adjunct to reduce bleb failure after first-time trabeculectomy: one year results","volume":"50","author":"Brar","year":"2009","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3341\/kjo.2010.24.1.47","article-title":"Subconjunctival bevacizumab as an adjunct to trabeculectomy in eyes with refractory glaucoma: a case series","volume":"24","author":"Choi","year":"2010","journal-title":"Korean Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD009782.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1442-9071.2012.02798.x","article-title":"Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study","volume":"40","author":"Chua","year":"2012","journal-title":"Clinical and Experimental Ophthalmology"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0011|cit11","article-title":"Short-term results of trabeculectomy using adjunctive intracameral bevacizumab: a randomized controlled trial","author":"Fakhraie","journal-title":"Journal of Glaucoma"},{"issue":"12","key":"10.1002\/14651858.CD009782.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ophtha.2008.06.009","article-title":"Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study","volume":"115","author":"Grewal","year":"2008","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD009782.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/j.1442-9071.2011.02608.x","article-title":"Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year","volume":"40","author":"Jurkowska-Dudzi\u0144ska","year":"2012","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD009782.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ajo.2010.03.025","article-title":"Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study","volume":"150","author":"Kahook","year":"2010","journal-title":"American Journal of Ophthalmology"},{"issue":"8","key":"10.1002\/14651858.CD009782.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/IJG.0000000000000194","article-title":"Efficacy of adjunctive subconjunctival bevacizumab on the outcomes of primary trabeculectomy with mitomycin C: a prospective randomized placebo-controlled trial","volume":"24","author":"Kiddee","year":"2015","journal-title":"Journal of Glaucoma"},{"issue":"7","key":"10.1002\/14651858.CD009782.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/IJG.0b013e3181efbea5","article-title":"Adjunctive use of bevacizumab versus mitomycin C with Ahmed valve implantation in treatment of pediatric glaucoma","volume":"20","author":"Mahdy","year":"2011","journal-title":"Journal of Glaucoma"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.oftal.2014.09.010","article-title":"Comparison study on the efficacy and safety of bevacizumab versus mitomycin C as adjuvants intrabeculectomy","volume":"90","author":"Mart\u00edn Giral","year":"2015","journal-title":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"},{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2011.03.013","article-title":"Anti-vascular endothelial growth factor therapy in glaucoma filtration surgery","volume":"152","author":"Mathew","year":"2011","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD009782.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3928\/15428877-20110316-02","article-title":"Adjunctive bevacizumab in patients undergoing Ahmed valve implantation: a pilot study","volume":"43","author":"Rojo-Arnao","year":"2011","journal-title":"Ophthalmic Surgery, Lasers and Imaging"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2147\/OPTH.S67730","article-title":"Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery","volume":"8","author":"Saeed","year":"2014","journal-title":"Clinical Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD009782.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jop.2012.0250","article-title":"The effect of bevacizumab on the outcome of trabeculectomy with 5-Fluorouracil","volume":"29","author":"Suh","year":"2013","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bjophthalmol-2013-303966","article-title":"Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study","volume":"98","author":"Vandewalle","year":"2014","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"Article ID 3841","DOI":"10.1155\/2013\/384134","article-title":"Subconjunctival bevacizumab injection in glaucoma filtering surgery: a case control series","volume":"2013","author":"Wang","year":"2013","journal-title":"ISRN Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"e88403","DOI":"10.1371\/journal.pone.0088403","article-title":"Anti-VEGF agents with or without antimetabolites in trabeculectomy for glaucoma: a meta-analysis","volume":"9","author":"Xiong","year":"2014","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0025|cit25","unstructured":"NCT00892398 Trabeculectomy with mitomycin c associated with sub-conjunctival injection of ranibizumab clinicaltrials.gov\/show\/NCT00892398"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0026|cit26","unstructured":"NCT01166594 Use of bevacizumab in trabeculectomy surgery clinicaltrials.gov\/ct2\/show\/NCT01166594"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0027|cit27","unstructured":"NCT01263834 Results of adjunctive intraoperative bevacizumab injection on trabeculectomy outcome clinicaltrials.gov\/ct2\/show\/NCT01263834"},{"issue":"4","key":"10.1002\/14651858.CD009782.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"American Journal of Ophthalmology"},{"issue":"7454","key":"10.1002\/14651858.CD009782.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jss.2008.04.023","article-title":"The role of vascular endothelial growth factor in wound healing","volume":"153","author":"Bao","year":"2009","journal-title":"Journal of Surgical Research"},{"issue":"10","key":"10.1002\/14651858.CD009782.pub2-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007325.pub2","article-title":"Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion","author":"Braithwaite","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009782.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD009782.pub2-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004399.pub3","article-title":"Medical versus surgical interventions for open angle glaucoma","author":"Burr","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD009782.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006259.pub2","article-title":"Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery","author":"Cabourne","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009782.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1002\/14651858.CD009782.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009782.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2125.2008.03278.x","article-title":"Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up","volume":"66","author":"Costagliola","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0038|cit38","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: \u00a0Analysing data and undertaking meta-analyses In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2741\/1184","article-title":"Wound healing: an overview of acute, fibrotic and delayed healing","volume":"9","author":"Diegelmann","year":"2004","journal-title":"Frontiers in Bioscience"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007059.pub2","article-title":"Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma","author":"Eldaly","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9605","key":"10.1002\/14651858.CD009782.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(07)61904-7","article-title":"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial","volume":"370","author":"Escudier","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD009782.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","article-title":"Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up","volume":"153","author":"Gedde","year":"2012","journal-title":"American Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD009782.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/jop.2007.0036","article-title":"Role of intravitreal bevacizumab in neovascular glaucoma","volume":"23","author":"Gheith","year":"2007","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0044|cit44","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0045|cit45","unstructured":"GRADEpro Guideline Development Tool [Software]. McMaster University (developed by Evidence Prime, Inc, 2015) Available from www.gradepro.org"},{"issue":"27","key":"10.1002\/14651858.CD009782.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001132.pub2","article-title":"5-Fluorouracil for glaucoma surgery","author":"Green","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010425.pub2","article-title":"Subcutaneous closure versus no subcutaneous closure after non-caesarean surgical procedures","author":"Gurusamy","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0049|cit49","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: \u00a0Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0050|cit50","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane-handbook.org"},{"issue":"23","key":"10.1002\/14651858.CD009782.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000099248","article-title":"Intravitreal bevacizumab for filtering surgery","volume":"39","author":"Jonas","year":"2007","journal-title":"Ophthalmic Research"},{"issue":"2","key":"10.1002\/14651858.CD009782.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3928\/1542-8877-20060301-12","article-title":"Needle bleb revision of encapsulated filtering bleb with bevacizumab","volume":"37","author":"Kahook","year":"2006","journal-title":"Ophthalmic Surgery, Lasers and Imaging"},{"issue":"3","key":"10.1002\/14651858.CD009782.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2010.03.028","article-title":"Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study","volume":"150","author":"Kinge","year":"2010","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD009782.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0039-6257(03)00038-9","article-title":"Antifibrotics and wound healing in glaucoma surgery","volume":"48","author":"Lama","year":"2003","journal-title":"Survey of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD009782.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","article-title":"A twenty-year follow-up study of trabeculectomy: risk factors and outcomes","volume":"119","author":"Landers","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD009782.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jemt.10249","article-title":"Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix","volume":"60","author":"Li","year":"2003","journal-title":"Microscopy Research Technique"},{"issue":"11","key":"10.1002\/14651858.CD009782.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","article-title":"Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery","volume":"50","author":"Li","year":"2009","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"7509","key":"10.1002\/14651858.CD009782.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","article-title":"Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials","volume":"331","author":"Maier","year":"2005","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD009782.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ophtha.2010.03.045","article-title":"A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2","volume":"117","author":"Michaelides","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD009782.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/bjo.83.7.814","article-title":"Risk factors for failures of trabeculectomies performed without antimetabolites","volume":"83","author":"Mietz","year":"1999","journal-title":"British Journal of Ophthalmology"},{"issue":"26","key":"10.1002\/14651858.CD009782.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009782.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD009782.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.ophtha.2009.04.023","article-title":"Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study","volume":"116","author":"Nguyen","year":"2009","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD009782.pub2-BIB0066|cit66","first-page":"1445","article-title":"Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing","volume":"152","author":"Nissen","year":"1998","journal-title":"American Journal of Pathology"},{"issue":"10","key":"10.1002\/14651858.CD009782.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"12","key":"10.1002\/14651858.CD009782.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1167\/iovs.10-5669","article-title":"Antifibrotic activity of bevacizumab on human Tenon's fibroblasts in vitro","volume":"51","author":"O'Neill","year":"2010","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD009782.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"14","key":"10.1002\/14651858.CD009782.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"24","key":"10.1002\/14651858.CD009782.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0073|cit73","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Guyatt GH (editors) Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"8","key":"10.1002\/14651858.CD009782.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005139.pub3","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","author":"Solomon","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009782.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"c2459","DOI":"10.1136\/bmj.c2459","article-title":"Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study","volume":"340","author":"Tufail","year":"2010","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1002\/14651858.CD009782.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0002-9394(02)01459-9","article-title":"Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure","volume":"133","author":"Wax","year":"2002","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD009782.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002897.pub2","article-title":"Intraoperative mitomycin C for glaucoma surgery","author":"Wilkins","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009782.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archophthalmol.2009.14","article-title":"Pegaptanib sodium for macular edema secondary to central retinal vein occlusion","volume":"127","author":"Wroblewski","year":"2009","journal-title":"Archives of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD009782.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jop.2008.0088","article-title":"Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma","volume":"25","author":"Yuzbasioglu","year":"2009","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009782.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009782","article-title":"Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery","author":"Cheng","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009782.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:48:47Z","timestamp":1786362527000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009782.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009782.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,15]]}}}